Novel Drug Delivery Technologies: Innovative Strategies for Drug Re-Positioning
暫譯: 新型藥物傳遞技術：藥物重新定位的創新策略

Misra, Ambikanandan, Shahiwala, Aliasagar

Novel Drug Delivery Technologies: Innovative Strategies for Drug Re-Positioning
  • 出版商: Springer
  • 出版日期: 2020-02-12
  • 售價: $7,160
  • 貴賓價: 9.5 折 $6,802
  • 語言: 英文
  • 頁數: 511
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 9811336415
  • ISBN-13: 9789811336416

    • 海外代購書籍(需單獨結帳)

相關主題

商品描述

The application of drug delivery is a valuable, cost-effective lifecycle management resource. By endowing drugs with new and innovative therapeutic benefits, drug delivery systems extend products' profitable lifecycle, giving pharmaceutical companies competitive and financial advantages, and providing patients with improved medications. Formulation development is now being used to create new dosage forms for existing products, which not only reduces the time and expense involved in new drug development, but also helps with regard to patent protection and bypassing existing patents. Today's culture demands convenience, a major factor determining adherence to drug therapy. Over the past few years, patient convenience-oriented research in the field of drug delivery has yielded a range of innovative drug-delivery options. As a result, various drug-delivery systems, including medicated chewing gums, oral dispersible tablets, medicated lozenges and lollipops, have now hit the market and are very popular. These dosage forms offer a highly convenient way to dose medications, not only for special population groups with swallowing difficulties, such as children and the elderly, but for the general populace as well. This book provides valuable insights into a number of formulation design approaches that are currently being used, or could be used, to provide new benefits from existing drug molecules.

商品描述(中文翻譯)

藥物傳遞的應用是一個有價值且具成本效益的生命週期管理資源。透過賦予藥物新的創新療效，藥物傳遞系統延長了產品的獲利生命週期，為製藥公司提供了競爭和財務優勢，並為患者提供了改善的藥物。配方開發現在被用來為現有產品創造新的劑型，這不僅減少了新藥開發所需的時間和費用，還有助於專利保護和繞過現有專利。當今的文化要求便利性，這是決定藥物治療依從性的一個主要因素。在過去幾年中，藥物傳遞領域以患者便利性為導向的研究產生了一系列創新的藥物傳遞選擇。因此，各種藥物傳遞系統，包括藥用口香糖、口服可分散片、藥用喉糖和棒棒糖，現在已經上市並且非常受歡迎。這些劑型為用藥提供了一種非常便利的方式，不僅適合有吞嚥困難的特殊人群，如兒童和老年人，也適合一般民眾。本書提供了對當前正在使用或可以使用的多種配方設計方法的寶貴見解，以便從現有藥物分子中提供新的益處。

作者簡介

Professor Ambikanandan Misra is Professor in Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda. Previously, he held Dean for the Faculty of Technology & Engineering (August 2011 to December 2015). Dr. Misra has been associated with the field of pharmaceutical sciences for more than 39 years. He has 8 books, 43 book chapters and 170 peer-reviewed publications in reputed journals to his credit, and holds 9 national and international patents. He has completed 22 research projects funded by the government and pharmaceutical industry and is the recipient of National award for Thrust Area programme in Technical Education (TAPTEC) project funded by AICTE, International award for Outstanding Manuscript by American Association of Pharmaceutical Scientists (AAPS) in 2008 and Best Reviewers in Pharmaceutical Sciences for Elsevier journals by Elsevier in 2011. He serves on the Editorial Board of 15 international journals, and as a reviewer for more than 50 international journals.

With more than 15 years of teaching and research experience, Aliasgar Shahiwala is currently a Professor at the Department of Pharmaceutics and Program Director for Postgraduate Studies at Dubai Pharmacy College, Dubai. His postdoctoral research at Northeastern University, USA was specifically focused on applications of nanotechnology in the fields of drug delivery and drug targeting. Professor Shahiwala has authored several international publications, including over 40 peer-reviewed articles in reputed journals, 2 books, and 6 book chapters. In addition to serving as a reviewer, Editorial Board member and invited conference speaker, he has more than 3 years of experience working in the formulation and development divisions of large-scale pharmaceuticals manufacturers in India.

作者簡介(中文翻譯)

安比卡南丹·米斯拉教授是巴羅達大學藥學院的教授。之前，他曾擔任技術與工程學院的院長（2011年8月至2015年12月）。米斯拉博士在藥學科學領域已有超過39年的經驗。他出版了8本書籍、43章書籍章節以及170篇在知名期刊上經過同行評審的論文，並擁有9項國內外專利。他完成了22個由政府和製藥行業資助的研究項目，並獲得了由AICTE資助的技術教育重點領域計劃（TAPTEC）國家獎、2008年美國藥學科學協會（AAPS）頒發的傑出手稿國際獎，以及2011年由Elsevier頒發的藥學科學最佳審稿人獎。他擔任15本國際期刊的編輯委員會成員，並為超過50本國際期刊擔任審稿人。

擁有超過15年的教學和研究經驗，阿利亞斯卡·沙希瓦拉目前是迪拜藥學院藥劑學系的教授及研究生課程主任。他在美國東北大學的博士後研究專注於納米技術在藥物傳遞和藥物靶向領域的應用。沙希瓦拉教授發表了多篇國際論文，包括在知名期刊上發表的40多篇經過同行評審的文章、2本書籍和6章書籍章節。除了擔任審稿人、編輯委員會成員和受邀會議演講者外，他在印度的大型製藥公司配方和開發部門工作了超過3年。

類似商品